-
-
-
-
-
-
-
Charles River Laboratories Provides Update on Planned Divestitures
-
-
-
-
-
-
-
Charles River Labs plans divestitures, cost cuts following review
-
-
-
-
-
-
-
Charles River Laboratories (CRL) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY25 EPS Guidance
-
-
-
-
-
-
-
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
-
-
-
-
-
-
-
Charles River Laboratories Announces Third-Quarter 2024 Results
-
-
-
-
-
-
-
Argus Downgrades Charles River Labs (CRL) to Hold, 'bearish pattern of lower highs and lower lows'
-
-
-
-
-
-
-
Charles River Laboratories (CRL) Tops Q3 EPS by 36c ; Offers Guidance
-
1,197,260 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

